Hakim Benamer, MD

Original Contribution

Angiographic Predictors of Septal Collateral Tracking During Retrograde Percutaneous Coronary Intervention for Chronic Total Occlusion: Anatomical Analysis or Rolling the Dice?

04/01/2022

Thomas Hovasse , MD;

Hakim Benamer , MD;

Stephane Champagne , MD;

Thierry Lefèvre , MD;

Philippe Garot , MD;

Antoinette Neylon , MD;

Bernard Chevalier , MD;

Thierry Unterseeh , MD;

Yves Louvard , MD;

Francesca Sanguineti , MD;

Anna Maria Loppolo , MD;

The aim of this study was to identify independent angiographic predictors of collateral channel tracking success, microcatheter tracking failure, and complications in chronic total occlusion retrograde approach.

The aim of this study was to...

04/01/2022

Journal of Invasive Cardiology

Original Contribution

Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry

05/01/2022

Antoine Gommeaux , MD;

Vincent Malquarti , MD;

Denis Angoulvant , MD;

Clauset Cruchon , MD;

Keith G. Oldroyd , MD, MBChB, FRCP;

Christian Spaulding , MD;

Hakim Benamer , MD;

Thierry Lefèvre , MD;

Olivier Varenne , MD;

Janusz Lipiecki , MD;

Rajiv Rampat , MD;

Christophe Piot , MD;

François Brunelle , MD;

Rami el Mahmoud , MD;

Dual-antiplatelet treatment (DAPT) has conventionally been prescribed for 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. Recent evidence suggests that a duration of only 6 months may be...

Dual-antiplatelet treatment...

05/01/2022

Journal of Invasive Cardiology